These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Thyroidectomy remains an effective treatment option for Graves' disease. Weber KJ; Solorzano CC; Lee JK; Gaffud MJ; Prinz RA Am J Surg; 2006 Mar; 191(3):400-5. PubMed ID: 16490555 [TBL] [Abstract][Full Text] [Related]
3. Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids. Myśliwiec J; Kretowski A; Topolska J; Siewko K; Jakubczyk D; Szelachowska M; Mikita A; Kinalska I Horm Metab Res; 2001 Dec; 33(12):739-43. PubMed ID: 11753760 [TBL] [Abstract][Full Text] [Related]
4. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy. Molnár I Autoimmunity; 2007 Feb; 40(1):31-7. PubMed ID: 17364495 [TBL] [Abstract][Full Text] [Related]
6. The total rehabilitation of Graves' ophthalmopathy. DeSanto LW Laryngoscope; 1980 Oct; 90(10 Pt 1):1652-78. PubMed ID: 6893477 [TBL] [Abstract][Full Text] [Related]
7. Management of the active severe eye changes of Graves' disease. Werner SC Trans Am Acad Ophthalmol Otolaryngol; 1967; 71(4):631-7. PubMed ID: 6072401 [No Abstract] [Full Text] [Related]
8. Serum IL-18 levels are not increased in patients with untreated Graves' ophthalmopathy. Wakelkamp IM; Prummel MF; Wiersinga WM Horm Metab Res; 2004 Jan; 36(1):44-7. PubMed ID: 14983406 [TBL] [Abstract][Full Text] [Related]
9. Surgical method and results of levator aponeurosis transposition for Graves' eyelid retraction. Khan JA; Garden V; Faghihi M; Parvin M Ophthalmic Surg Lasers; 2002; 33(1):79-82. PubMed ID: 11820671 [TBL] [Abstract][Full Text] [Related]
10. A polymorphism of the 5' flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese. Kamizono S; Hiromatsu Y; Seki N; Bednarczuk T; Matsumoto H; Kimura A; Itoh K Clin Endocrinol (Oxf); 2000 Jun; 52(6):759-64. PubMed ID: 10848881 [TBL] [Abstract][Full Text] [Related]
11. Peripheral parameters of oxidative stress in patients with infiltrative Graves' ophthalmopathy treated with corticosteroids. Bednarek J; Wysocki H; Sowiński J Immunol Lett; 2004 May; 93(2-3):227-32. PubMed ID: 15158621 [TBL] [Abstract][Full Text] [Related]
13. Eyelid malpositions in Graves' ophthalmopathy. Waller RR Trans Am Ophthalmol Soc; 1982; 80():855-930. PubMed ID: 6897828 [No Abstract] [Full Text] [Related]
14. Obliteration of the circadian rhythm of intraocular pressure in Graves' ophthalmopathy. De Remigis P; Vianale L; Mastropasqua L; di Marzio G; Gallenga P; Sensi S Prog Clin Biol Res; 1990; 341A():101-4. PubMed ID: 2217222 [No Abstract] [Full Text] [Related]
15. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease. de Bellis A; Perrino S; Coronella C; Sansone D; Ruocco G; Tirelli G; Di Martino S; Conte M; Bellastella G; Wall JR; Bellastella A; Bizzarro A Clin Endocrinol (Oxf); 2004 Jun; 60(6):694-8. PubMed ID: 15163332 [TBL] [Abstract][Full Text] [Related]
16. Lithium in the preoperative preparation of Graves' disease. Takami H Int Surg; 1994; 79(1):89-90. PubMed ID: 8063564 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of Graves' ophthalmopathy with oral or intravenous corticosteroids]. Brauer VF; Scholz GH Med Klin (Munich); 2004 Feb; 99(2):71-6. PubMed ID: 14963657 [TBL] [Abstract][Full Text] [Related]
20. Endoscopic orbital decompression for Graves' ophthalmopathy. Levy J; Puterman M; Lifshitz T; Marcus M; Segal A; Monos T Isr Med Assoc J; 2004 Nov; 6(11):673-6. PubMed ID: 15562804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]